---
id: 198
title: Infections in Asplenia (OPSI)
category: special_populations
subcategory: immunocompromised
tags: [asplenia, OPSI, encapsulated-bacteria, pneumococcus, meningococcus, Hib, prophylaxis, vaccines]
difficulty: high
---

## Question

How are asplenic patients managed? Use **"Encapsulated Bacteria (S. pneumo, N. meningitidis, H. flu) → Vaccines (Pneumo, Mening, Hib) + Prophylactic PCN"** framework.

## Answer

### **Overwhelming Post-Splenectomy Infection (OPSI):**

**Definition:** Fulminant sepsis in asplenic/hyposplenic patients

**Pathogens:**
- **Encapsulated bacteria** (most common):
  - ***Streptococcus pneumoniae*** (50-90% of OPSI cases)
  - ***Neisseria meningitidis***
  - ***Haemophilus influenzae* type b**
- **Other:** *Capnocytophaga canimorsus* (dog bite), *Babesia microti* (tick), malaria (severe)

**Presentation:**
- **Rapid progression:** Fever → septic shock → DIC → death (within hours)
- **Mortality:** 50-70% despite antibiotics

**Risk:**
- **Highest first 2 years** post-splenectomy (but lifelong risk)
- **Functional asplenia** (sickle cell disease, celiac disease, severe liver disease, graft-vs-host disease)

### **Prevention Strategies:**

**1. Vaccination (MOST IMPORTANT):**

**Pneumococcal:**
- **PCV20 (Prevnar 20) × 1** (single dose, preferred)
- OR **PCV15 (Prevnar 15) × 1 → PPSV23 (Pneumovax 23) ≥8 weeks later**
- **If PPSV23 previously given:** Give PCV20 ≥1 year after last PPSV23

**Meningococcal:**
- **MenACWY (Menactra, Menveo):** 2 doses (0, 8-12 weeks) → **booster every 5 years**
- **MenB (Bexsero, Trumenba):** 2-3 dose series → **booster every 2-3 years** (consider)

***H. influenzae* Type b (Hib):**
- **If NOT vaccinated as child:** 1 dose

**Annual:**
- **Influenza vaccine** (annual)

**Timing:**
- **Elective splenectomy:** Vaccinate **≥2 weeks before** surgery (optimal immune response)
- **Emergent splenectomy:** Vaccinate **≥2 weeks after** surgery (or before discharge if >2 weeks post-op)

**2. Antibiotic Prophylaxis:**

**Indications:**
- **All asplenic patients** (especially first 2 years post-splenectomy)
- **Consider lifelong** for high-risk (children, sickle cell disease, immunocompromised, prior OPSI)

**Regimen:**
- **Penicillin VK 250-500mg PO BID** (preferred)
- OR **amoxicillin 250-500mg PO daily**
- OR **erythromycin 250mg PO BID** (if penicillin allergy)

**Controversies:**
- **Duration:** Lifelong vs. first 2 years (no consensus)
- **Compliance often poor** (lifelong antibiotics challenging)

**3. Emergency Antibiotics (Patient Education):**

**Standby Prescription:**
- **Give patient emergency antibiotic prescription** (amoxicillin-clavulanate, levofloxacin)
- **Instructions:** Start immediately if fever >38.5°C (101.3°F) AND unable to access medical care within 2 hours
- **Seek medical attention urgently**

**Emergency Antibiotic Options:**
- **Amoxicillin-clavulanate 875/125mg PO BID**
- **Levofloxacin 750mg PO daily**
- **Ceftriaxone 1-2g IM × 1** (if available, vomiting)

**4. Patient Education:**

**Key Messages:**
- **Fever = medical emergency** (seek care immediately)
- **Wear medical alert bracelet** (identifies asplenia)
- **Carry emergency antibiotic** prescription
- **Avoid dog/animal bites** (*Capnocytophaga* risk)
- **Tick precautions** (babesiosis risk)
- **Malaria prophylaxis** if traveling to endemic areas (severe malaria risk)

### **Empiric Treatment of Suspected OPSI:**

**IV Antibiotics (Immediately):**
- **Ceftriaxone 2g IV q12h** (covers pneumococcus, meningococcus, *H. influenzae*)
- **+ Vancomycin 15-20 mg/kg IV q8-12h** (if MRSA risk, pending cultures)

**Supportive Care:**
- **Aggressive fluid resuscitation**
- **ICU monitoring** (rapid progression common)

**Do NOT Delay Antibiotics** (waiting for cultures can be fatal)

### **Special Situations:**

**Dog/Cat Bite (Asplenic Patient):**
- **High risk *Capnocytophaga canimorsus*** (asplenia = 200× increased risk)
- **Prophylaxis:** **Amoxicillin-clavulanate 875/125mg PO BID × 3-5 days**
- **Treat infection:** Amoxicillin-clavulanate, ceftriaxone, doxycycline

**Babesiosis:**
- **Severe disease** in asplenic patients (high parasitemia, ARDS, shock)
- **Treatment:** Atovaquone + azithromycin (mild-moderate) OR clindamycin + quinine (severe)
- **Exchange transfusion** if parasitemia >10% or severe

**Malaria:**
- **Severe disease** in asplenic patients
- **Prophylaxis essential** if traveling to endemic areas
- **Treatment:** IV artesunate (severe), atovaquone-proguanil or artemether-lumefantrine (uncomplicated)

## Key Points

### **Encapsulated Bacteria = Highest Risk:**
- ***S. pneumoniae*** (50-90% of OPSI)
- ***N. meningitidis*, *H. influenzae* type b**
- **Spleen removes encapsulated bacteria** (opsonization impaired without spleen)

### **Vaccines = MOST Important:**
- **Pneumococcal:** PCV20 (preferred single dose)
- **Meningococcal:** MenACWY (2 doses, booster q5y) + MenB (consider, booster q2-3y)
- **Hib:** 1 dose (if not vaccinated as child)
- **Vaccinate ≥2 weeks before** elective splenectomy (optimal response)

### **Antibiotic Prophylaxis:**
- **Penicillin VK 250-500mg PO BID** (lifelong or ≥2 years)
- **Especially:** Children, sickle cell disease, prior OPSI, immunocompromised

### **Fever = Emergency:**
- **Seek medical care immediately** (OPSI can progress to death within hours)
- **Start emergency antibiotics** if unable to access care within 2h

### **Clinical Pearls:**
- **Asplenia = OPSI risk** (fulminant sepsis from encapsulated bacteria)
- **Vaccines:** PCV20 + MenACWY (2 doses, booster q5y) + MenB + Hib
- **Prophylaxis:** Penicillin VK 250-500mg BID (lifelong or ≥2 years)
- **Fever = emergency** (start antibiotics immediately, seek urgent care)
- **Dog bite:** Amoxicillin-clavulanate prophylaxis (*Capnocytophaga* risk)

## Sources

- [IDSA: Asplenia Management Guidelines 2024]
- [CDC: Vaccination of Asplenic Patients 2024]

## Media

N/A
